Manisha Koirala was diagnosed with stage IV ovarian cancer in 2012. She later made a recovery after undergoing treatment in ...

For ovarian cysts that cause pain, medications such as acetaminophen, ibuprofen, or another non-steroidal anti-inflammatory ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

In a recent clip, Dr Jackson-Spence shared a number of different symptoms that could actually be something more serious - ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

She had made repeated visits to the GP with symptoms, which over the following years became persistent and gradually worse.

A cancer survivor is raising awareness about the importance of genetic testing. Why she believes it can be imperative to ...

The addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian cancer with high-risk prognostic factors.

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies.

Feeling Low? Your Ultra-Processed Food Habit Might Be to BlameA recent study published in Food Science & Nutrition has highlighted a strong ...

ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.

What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...